Advertisement

Diet and Childhood Cancer

Preliminary Evidence
  • Greta R. Bunin
  • Joan M. Cary
Part of the Nutrition ◊ and ◊ Health book series (NH)

Abstract

Cancer is the most common fatal disease of childhood in the United States. Between ages 1 and 15, only accidents kill more children. Approximately 14/100,000 children develop cancer each year, or about 7500 children in the United States (1,2). This incidence rate indicates that about 1 in 500 children develop cancer before the age of 15. The common cancers of childhood are not those of later life; leukemia accounts for about one-third of childhood cancers and brain tumors about one-fifth. The other major cancers, in order of frequency, are lymphoma, neuroblastoma, Wilms’ tumor, soft tissue sarcoma, osteogenic sarcoma, and retinoblastoma (2). Since the early 1970s, the incidence of childhood cancer appears to be increasing slowly (1), but whether the observed increase reflects better diagnosis or real change is not known. The same time period has also seen a dramatic improvement in the survival of children with cancer, with approx 70% of these children now alive 5 yr after diagnosis (2). However, some are left with long-term medical and cognitive problems.

Keywords

Brain Tumor Acute Lymphocytic Leukemia Childhood Cancer Orange Juice Vegetable Consumption 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Ries LAG, Miller BA, Hankey BF, et al. eds. SEER Cancer Statistics Review, 1973–1991: Tables and Granhs, National Cancer Institute NIH Pub. No. 94–2789. Bethesda. MD, 1994.Google Scholar
  2. 2.
    Bleyer A. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355–367.CrossRefGoogle Scholar
  3. 3.
    Preston-Martin S, Yu MC, Benton B, Henderson BE. N-nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 1982; 42: 5240–5245.Google Scholar
  4. 4.
    Howe GR, Burch JD, Chiarelli AM, Risch HA, Choi BCK. An exploratory case-control study of brain tumors in children. Cancer Res 1989; 49: 4349–4352.Google Scholar
  5. 5.
    Kuijten RR, Bunin GR, Nass CC, Meadows AT. Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. Cancer Res 1990; 50: 2608–2612.Google Scholar
  6. 6.
    Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. New Engl J Med 1993; 329: 536–541.CrossRefGoogle Scholar
  7. 7.
    Bunin GR, Kuijten RR, Boesel CP, Buckley JD, Meadows AT. Maternal diet and risk of astrocytic glioma in children: a report from the Children’s Cancer Group. Cancer Causes Control 1994; 5: 177–187.CrossRefGoogle Scholar
  8. 8.
    McCredie M, Maisonneuve P, Boyle P. Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994. 56: 11–15.CrossRefGoogle Scholar
  9. 9.
    McCredie M, Maisonneuve P, Boyle P. Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994: 56: 6–10CrossRefGoogle Scholar
  10. 10.
    Sarasua S, Savitz DA. Cured and broiled meat consumption in relation to childhood cancer. Cancer Causes Control 1994; 5: 141–148.CrossRefGoogle Scholar
  11. 11.
    Cordier S, Iglesias M–J, Goaster CL, Guyot M–M, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer 1994; 59: 776–782.CrossRefGoogle Scholar
  12. 12.
    Peters JM, Preston-Martin S, London SJ, Bowman JD, Buckley JD, Thomas DC. Processed meats and risk of childhood leukemia. Cancer Causes Control1994; 5: 195–202.Google Scholar
  13. 13.
    Shu XO, Gao YT, Brinton LA, Linet MS, Tu JT, Zheng W, Fraumeni JF. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988; 62: 635–644.CrossRefGoogle Scholar
  14. 14.
    Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748–9752.CrossRefGoogle Scholar
  15. 15.
    Butterworth CE. Folate deficiency and cancer. In: Micronutrients in Health and in Disease Prevention. Bendich A, Butterworth CE Jr., eds. New York: Marcel Dekker, 1991; 165–183.Google Scholar
  16. 16.
    Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratol 1995; 51: 435–445.CrossRefGoogle Scholar
  17. 17.
    Nelson KG, Sakai Y, Eitzman B, Steed T, McLachlan J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 1994; 5: 595–606.Google Scholar
  18. 18.
    McLachlan JA, Newbold RR. Estrogens and development. Environ Health Perspect 1987; 75: 25–27.CrossRefGoogle Scholar
  19. 19.
    Lijinsky W. Chemistry and biology of N-nitroso compounds. New York: Cambridge University Press, 1992.Google Scholar
  20. 20.
    National Academy of Sciences. The health effects of nitrate, nitrite and N-nitroso compounds. Washington: National Academy Press, 1981.Google Scholar
  21. 21.
    Bartsch H, Castegnaro M, O’;Neill IK, Okada M (eds.) N-nitroso compounds: occurrence and biological effects. Lyon: International Agency for Research on Cancer, 1982.Google Scholar
  22. 22.
    Howe GR, Harrison L, Jain M. A short diet history for assessing dietary exposure to N-nitrosamines in epidemiologic studies. Am J Epidemiol 1986; 124: 595–602.Google Scholar
  23. 23.
    Mirvish SS. Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers. Cancer Res 1994; 54: 1948s–1951s.Google Scholar
  24. 24.
    Young JL, Ries LG, Silverbert E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than 15 years. Cancer 1986; 58: 598–602.CrossRefGoogle Scholar
  25. 25.
    Gurney JF, Severson RK, Davis S, Robision LL. Incidence of cancer in children in the United States. Cancer1995; 75: 2186–2195.Google Scholar
  26. 26.
    MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131–137.CrossRefGoogle Scholar
  27. 27.
    Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988; 260: 3141–3145.CrossRefGoogle Scholar
  28. 28.
    Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989; 150: 613–619.Google Scholar
  29. 29.
    Shaw GM, Lammer EJ, Wasserman CR, O’;Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 346: 393–396.CrossRefGoogle Scholar
  30. 30.
    Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993; 306: 1645–1648.CrossRefGoogle Scholar
  31. 31.
    Li De-Kun, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995; 6: 212–218.CrossRefGoogle Scholar
  32. 32.
    Malvy DJ-M, Burtschy B, Arnaud J, Sonmmelet D, Leverger G, Dostalova L, Drucker J, Amedee-Manesme O, and the Cancer in Children and Antioxidant Micronutrients French Study Group. Serum beta-carotene and antioxidant micronutrients in children with cancer. Int J Epidemiol1993; 22: 761–771.Google Scholar
  33. 33.
    Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 1989; 49: 6137–6143.Google Scholar
  34. 34.
    Burch JD, Craib KJP, Choi BCK, Miller AB, Risch HA, Howe GR. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987; 78: 601–609.Google Scholar
  35. 35.
    Ahlbom A, Navier IL, Norell S, Olin R, Spannare B. Nonoccupational risk indicators for astrocytomas in adults. Am J Epidemiol 1986; 124: 334–337.Google Scholar
  36. 36.
    Boeing H, Schlehofer B, Blettner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 1993; 53: 561–565.CrossRefGoogle Scholar
  37. 37.
    Ryan P, Lee MW, North JB. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992; 51: 20–27.CrossRefGoogle Scholar
  38. 38.
    Giles GG, McNeil JJ, Donnan G, Webley C, Staples MP, Ireland P, Hurley SF, Salzberg M. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994; 59: 357–362.CrossRefGoogle Scholar
  39. 39.
    Ross JA, Davies SM, Potter JD, Robison LL. Epidemiology of childhood leukemia, with a focus on infants. Enidemiol Rev 1994: 16: 243–272.Google Scholar
  40. 40.
    Austin CA, Patel S, Ono K, Nakane H, Fisher LM. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 1992; 282: 883–889.Google Scholar
  41. 41.
    Yamashita Y, Kawada S–Z, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 1990; 39: 737–744.CrossRefGoogle Scholar
  42. 42.
    Pierpoint WS. Flavonoids in the human diet. In: Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships. Cody V, Middleton E, eds. New York: Alan R. Liss, Inc., 1986: 125–140.Google Scholar
  43. 43.
    Epstein RI. Topoisomerases in human disease. Lancet 1988; 1: 521–524.CrossRefGoogle Scholar
  44. 44.
    Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991; 2: 327–342.Google Scholar
  45. 45.
    Kwiatkowski A. Dietary and other environmental risk factors in acute leukaemias: A case-control study of 119 patients. Eur J Cancer Prev 1993; 2: 139–146.CrossRefGoogle Scholar
  46. 46.
    Hursting SD, Margolin BH, Switzer BR. Diet and human leukemia: an analysis of international data. Prev Med 1993; 22: 409–422.CrossRefGoogle Scholar
  47. 47.
    Gross L. Inhibition of the development of leukemia in mice and rats after reduction in food intake. Cancer 1988; 62: 1463–1465.CrossRefGoogle Scholar
  48. 48.
    Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990; 62: 304–308.CrossRefGoogle Scholar
  49. 49.
    Golding J, Greenwood R, Birmingham K, mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. Br Med J 1992; 305: 341–346.CrossRefGoogle Scholar
  50. 50.
    Ekelund H, Finnstrom 0, Gunnarskog J, Kallen B, Larsson Y. Administration of vitamin K to newborn infants and childhood cancer. Br Med J 1993; 307: 89–91.CrossRefGoogle Scholar
  51. 51.
    Klebanoff MA, Read JS, Mills JL, Shiono PH. The risk of childhood cancer after neonatal exposure to vitamin K. New Engl J Med 1993; 329: 905–908.CrossRefGoogle Scholar
  52. 52.
    Grufferman S, Wang HH, Delong ER, Kimm SYS, Delzell ES, Falletta JM. Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 1982; 68: 107–113.Google Scholar
  53. 53.
    Bunin GR, Meadows AT, Emanuel BS, Buckley JD, Woods WG, Hammond GD. Pre- and post-conception factors associated with heritable and non-heritable retinoblastoma. Cancer Res 1989; 49: 5730–5735.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Greta R. Bunin
  • Joan M. Cary

There are no affiliations available

Personalised recommendations